Potassium Phosphate
Active ingredient
Sold as K Phos Original · KALI PHOSPHORICUM · JetZone Jet Lag Prevention
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Intravenous, Oral
- Markets covered
- 2
- Products on record
- 5
- FDA reports (12 mo)
- 162
Overview
Plain-language summary, compiled from the cited regulatory records
Potassium Phosphate is a mineral supplement [1]. It is approved for use as indicated or as directed by a physician [1].
This active ingredient is available under various brand names, including K Phos Original, KALI PHOSPHORICUM, and JetZone Jet Lag Prevention [1].
In the past 12 months, there have been 162 adverse event reports associated with Potassium Phosphate [2]. The most frequently reported conditions include Condition Aggravated, Off Label Use, Respiratory Failure, Encephalopathy, and Diarrhoea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | April 30, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
4 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 074959bb-0638-4e… · revised September 27, 2021 [PDF]
- [2]Health Canada (DPD) · 00711306 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.